Genetic (GENE) Can Begin Selling BREVAGen in Florida
Tweet Send to a Friend
Up)
Genetic Technologies Limited (Nasdaq: GENE) is pleased to announce that BREVAGen" has been cleared for sale into the State of Florida following the grant of a permit to the Company's Australian-based laboratory by the Clinical Laboratory Unit of the Florida Agency for Healthcare Administration ("AHCA").
This news follows the Company's July 2012 market update announcing the clearance of BREVAGen" for sale into the State of California. Combined, Florida and California represent between 15% and 20% of breast cancer incidence in the United States (based on breast cancer incidence rates: ACS Breast Cancer Facts & Figures 2011-12, ACS Cancer Facts & Figures 2012).
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
This news follows the Company's July 2012 market update announcing the clearance of BREVAGen" for sale into the State of California. Combined, Florida and California represent between 15% and 20% of breast cancer incidence in the United States (based on breast cancer incidence rates: ACS Breast Cancer Facts & Figures 2011-12, ACS Cancer Facts & Figures 2012).
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Salix Pharma (SLXP) Reports Positive Results From Two Budesonide Foam Phase 3s
- Rigel Pharma (RIGL) Advances R348 to Phase 2
- Boston Scientific (BSX) Reports Positive Results from NG PROMUS, EVOLVE
Create E-mail Alert Related Categories
Corporate News, FDA
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
